AlphaYouPB
Schedule 13G filing
PharmAla Biotech Holdings Inc. disclosed a 17.3% stake in Jupiter Neurosciences, Inc. (JUNS)
PharmAla Biotech Holdings Inc. reported owning 17.3% of Jupiter Neurosciences, Inc. (JUNS) (132,867 shares) in a Schedule 13G filed Sep 22, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 22, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.